You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: August 14, 2024

Details for Patent: 10,426,782


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,426,782 protect, and when does it expire?

Patent 10,426,782 protects OJEMDA and is included in two NDAs.

This patent has eighteen patent family members in sixteen countries.

Summary for Patent: 10,426,782
Title:Pharmaceutical formulations of a pan-RAF kinase inhibitor and processes for their preparation
Abstract:The invention relates to a pharmaceutical composition comprising Compound 1 or a pharmaceutically acceptable salt thereof for the treatment of cancer and a process for its preparation. The invention also relates to administering the pharmaceutical composition to a patient according to an intermittent dosing regimen.
Inventor(s):Brake Rachael L., Bozon Viviana, Chow Ching-Kuo J., Dinunzio James C., Galvin Katherine M., Kannan Karuppiah, Kodono Yuki, Xu Qunli
Assignee:MILLENNIUM PHARMACEUTICALS, INC.
Application Number:US15128714
Patent Claim Types:
see list of patent claims
 

Drugs Protected by US Patent 10,426,782

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Day One Biopharms OJEMDA tovorafenib FOR SUSPENSION;ORAL 218033-001 Apr 23, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Day One Biopharms OJEMDA tovorafenib TABLET;ORAL 217700-001 Apr 23, 2024 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,426,782

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Brazil 112016022219 ⤷  Sign Up
Canada 2943808 ⤷  Sign Up
China 106456787 ⤷  Sign Up
Colombia 2016003340 ⤷  Sign Up
Costa Rica 20160483 ⤷  Sign Up
Dominican Republic P2016000254 ⤷  Sign Up
Eurasian Patent Organization 031190 ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.